Podium Session 4: Prostate Cancer

Session IV: Prostate Prostate cancer and imaging

Prostate cancer’s incidence, prevalence, etiology, and risk factors, and the influence of clinical trials on imaging technology development are discussed. One in seven Western men older than 70 will develop prostate cancer. The advent of prostate-specific antigen (PSA) screening means most men will now be diagnosed with early disease (85% not palpable on digital rectal exam (DRE), fewer grade 8...

Podium for the opposition?

This is quite a paradoxical era. Scientific research is in its most productive phase and it continues to produce many beneficial technologies for mankind. For example, we rapidly progress towards a better understanding of many diseases and come up with multiple new approaches to cure them. At the same time, however, the voices against science and technology have never been more shrill. But unsu...

PSA Screening in Prostate Cancer

Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...

Session 4: Machine Translation

About 2~ years ago, ARPA initiated a new program in Machine Translation (MT). Three projects were funded: CANI)II)E, built by IBM in New York; I,INGSTA'I~, built by Dragon Systems in Boston; and PAN(;I,()SS, a col laborat ion of the Computing Research Laboratory at New Mexico State University, the Center for Machine Translation at Carnegie Mellon University, and the Information Sciences Institu...

Session 4: Overview